HBIO icon

Harvard Bioscience

6.99 USD
+0.86
14.03%
At close Updated Apr 20, 4:00 PM EDT
1 day
14.03%
5 days
50%
1 month
32.64%
3 months
20.1%
6 months
75.63%
Year to date
7.21%
1 year
92.03%
5 years
-89.58%
10 years
-78.16%
 

About: Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Employees: 339

0
Funds holding %
of 8,119 funds
0
Analysts bullish %
of 1 analysts
Positive news %
of articles
Price charts implemented using Lightweight Charts™